Studies have shown that neoadjuvant nivolumab may provide long-term benefits for people with non-small cell lung cancer.

Published Date: 17 Feb 2023

BACKGROUND: NSCLC is the most common and important cause of cancer worldwide. Assessment: The patient...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

A better option for mild to moderate depression?

2.

Tafasitamab-Based Combination Boosts PFS in Relapsed/Refractory Follicular Lymphoma

3.

The need for more Latinx participants in Alzheimer's trials is urgent.

4.

An ultrasound breast patch with conformability might help with early breast cancer detection.

5.

AI System Beats Radiologists in Detecting Clinically Significant Prostate Cancer


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot